Physician profile
Olayinka Aina
NPI 1295706976
$2,141.12
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $340 · 2021: $812 · 2022: $478 · 2023: $80.65 · 2024: $20.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $596.73 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $273.06 | 2019-2022 | |
| Abbvie INC. | $245.69 | 2021-2024 | Dalvance, Teflaro |
| Janssen Pharmaceuticals, INC | $166.76 | 2019-2022 | |
| Pfizer INC. | $130.31 | 2019-2021 | |
| Tosoh Bioscience, INC. | $95.00 | 2019 | |
| Merck Sharp & Dohme LLC | $82.65 | 2022 | |
| Biogen, INC. | $64.98 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $64.36 | 2019 | |
| Novo Nordisk INC | $60.81 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.64 | 2021-2022 | |
| Grifols USA, LLC | $51.51 | 2019-2021 | |
| Astellas Pharma US INC | $41.88 | 2019-2022 | |
| Radius Health, INC. | $35.41 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $30.11 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $29.15 | 2020-2022 | |
| Daiichi Sankyo INC. | $28.94 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $28.14 | 2022 | |
| Alkermes, INC. | $18.84 | 2022 | |
| Allergan, INC. | $17.10 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.67 | 2022 | |
| Hikma Pharmaceuticals USA | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olayinka Aina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.